Salt / ingredient
Dapagliflozin 5mg + Metformin Hydrochloride Extended Release 500mg
Controls sugar, protects heart/kidney + Controls blood sugar in type-2 diabetes
MRP data last verified: August 2026. Source: NPPA Pharma Sahi Daam, reproduced under the NPPA copyright policy.
Private-brand substitutes: kam se zyada
More about this medicine
Reference information
About Dapagliflozin
This information is from US FDA labels, for reference only. Always follow your doctor's advice.
Common side effects
- female genital mycotic infections
- nasopharyngitis
- urinary tract infections
- to report suspected adverse reactions
- contact zydus pharmaceuticals (usa) inc
Safety advice
- May affect the kidneys. Tell your doctor if you have kidney problems.
- Avoid or limit alcohol while taking this medicine.
- May cause low blood sugar. Watch for symptoms like shakiness, sweating, confusion.
- May affect the liver. Tell your doctor if you have liver problems.
- Stop use and seek emergency help if you have signs of a severe allergic reaction.
Uses
- dapagliflozin) is indicated: • To reduce the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular (CV) death, and hospitalization for heart failure in adults with chronic kidney disease at risk of progression.
- • To reduce the risk of CV death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure.
- • To reduce the risk of hospitalization for heart failure in adults with type 2 diabetes mellitus and either established CV disease or multiple CV risk factors.
- • As an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus.
- Limitations of Use • is not recommended for use to improve glycemic control in patients with type 1 diabetes mellitus .
How to take
- • Assess renal function prior to initiation and then as clinically indicated.
- Assess volume status and correct volume depletion before initiating.
- (2.1) • To improve glycemic control, the recommended starting dosage is 5 mg orally once daily.
- Dosage can be increased to 10 mg orally once daily for additional glycemic control.
- (2.2) • For all other indications, the recommended dosage is 10 mg orally once daily.
Frequently Asked Questions about Dapagliflozin 5mg + Metformin Hydrochloride Extended Release 500mg
What is the price of Dapagliflozin 5mg + Metformin Hydrochloride Extended Release 500mg in India?
The price of Dapagliflozin 5mg + Metformin Hydrochloride Extended Release 500mg in India depends on the manufacturer and channel. Official Government Jan Aushadhi generic rates start at ₹2.81 per unit.Private commercial brands vary from low-cost options to higher-priced branded formulations.
Is a Government Jan Aushadhi generic available for Dapagliflozin 5mg + Metformin Hydrochloride Extended Release 500mg?
Dapagliflozin 5mg + Metformin Hydrochloride Extended Release 500mg is listed under PMBI Jan Aushadhi (PMBI Code 2497) at ₹28.13 per pack.
How to find lower-cost substitutes for Dapagliflozin 5mg + Metformin Hydrochloride Extended Release 500mg?
Search the active salt formulation (Dapagliflozin 5mg + Metformin Hydrochloride Extended Release 500mg) on Sasta Parcha to view private-brand substitutes ranked strictly low-to-high by per-unit price. Always consult your prescribing doctor or pharmacist before changing medicine brands.